Fang Li is the founder of Allorion Therapeutics. Allorion Therapeutics has raised $105M in total funding. Latest round: Series B.
Fang Li is a Co-Founder and Chief Scientific Officer at Allorion Therapeutics, a precision medicine company developing small molecule drugs for cancer and autoimmune diseases. He co-founded the company in July 2020 and has served as CSO since inception.
Full founder directory · Investor directory · Company funding database · Fundraising library